Renal Histopathology of a Baboon Model with Type 2 Diabetes

被引:6
|
作者
Rincon-Choles, Hernan [1 ,2 ]
Abboud, Hanna E. [1 ,2 ]
Lee, Shuko [1 ]
Shade, Robert E. [3 ]
Rice, Karen S. [3 ]
Carey, K. Dee [3 ]
Comuzzie, Anthony G. [3 ,4 ]
Barnes, Jeffrey L. [1 ,2 ]
机构
[1] South Texas Vet Hlth Care Syst, Audie L Murphy Div, San Antonio, TX USA
[2] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA
[3] Southwest Reg Primate Res Ctr, San Antonio, TX USA
[4] Texas Biomed Res Inst, Dept Genet, San Antonio, TX USA
基金
美国国家卫生研究院;
关键词
glomerular basement membrane; mesangium; diabetic nephropathy; baboon; renal morphology; NOCTURNAL BLOOD-PRESSURE; ELDERLY HYPERTENSIVE PATIENTS; PAPIO-HAMADRYAS MODEL; HETEROGENEOUS NATURE; MESANGIOLYSIS; MICROALBUMINURIA; PATHOGENESIS; NEPHROPATHY; PROGRESSION; LESIONS;
D O I
10.1177/0192623312444025
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Naturally occurring type 2 diabetes has been found in a colony of baboons. Ongoing characterization of the baboon colony maintained at the Southwest National Primate Research Center has revealed a significant range of glucose sensitivity with some animals clearly diabetic. Seven baboons, four with diabetes and three without diabetes, underwent histopathological investigation. Three diabetic animals were diagnosed using fasting blood glucose, hemoglobin A1C, and intravenous glucose tolerance test, and a fourth one was known to have hyperglycemia. One control baboon and three baboons with diabetes had microalbuminuria. On kidney biopsy, diabetic baboons had thickening of the glomerular basement membrane and mesangial matrix expansion compared to controls. Immunohistochemistry showed the diabetic animals had increased mesangial expression of cellular fibronectin ED-A. Two diabetic animals with microalbuminuria had evidence of mesangiolysis with the formation of an early nodule. One diabetic animal had a Kimmestiel-Wilson nodule. We conclude that the baboon represents a useful primate model of diabetes and nephropathy that resembles the nephropathy associated with type 2 diabetes in humans.
引用
收藏
页码:1020 / 1030
页数:11
相关论文
共 50 条
  • [21] Altered renal sodium transporter expression in an animal model of type 2 diabetes mellitus
    Oh, Yun Kyu
    Joo, Kwon Wook
    Lee, Jay Wook
    Jeon, Un Sil
    Lim, Chun Soo
    Han, Jin Suk
    Knepper, Mark A.
    Na, Ki Young
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (06) : 1034 - 1041
  • [22] Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model
    Ohtomo, Shuichi
    Nangaku, Masaomi
    Izuhara, Yuko
    Takizawa, Shunya
    de Strihou, Charles van Ypersele
    Miyata, Toshio
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (04) : 1166 - 1172
  • [23] THE EFFECTS OF CHRONIC DAPAGLIFLOZIN TREATMENT ON THE RENAL MICROVASCULATURE IN A RAT MODEL OF TYPE 2 DIABETES
    Ow, Connie
    Sukumaran, Vijayakumar
    Ngo, Jennifer
    Du, Cheng Kun
    Fujiwara, Akihiro
    Tsuchimochi, Hirotsugu
    Hosoda, Hiroshi
    Evans, Roger
    Pearson, James
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1301 - 1301
  • [24] Altered expression of renal sodium transporters in the animal model of type 2 diabetes mellitus
    Heo, NJ
    Jang, HR
    Lee, JW
    Oh, YK
    Na, KY
    Joo, KW
    Han, JS
    FASEB JOURNAL, 2006, 20 (04): : A334 - A335
  • [25] Effect of obesity and lipotoxicity on pancreatic islet of langerhans amyloidosis in the baboon, a new model of type 2 diabetes mellitus (T2DM)
    Mendoza, Rodolfo G.
    Davalli, Alberto
    Chavez-Velazquez, Alberto O.
    Comuzzie, Anthony
    Tejero, Elizabeth
    Alvarenga, Juan C.
    Bastarrachea, Raul
    Zuo, Peng-Hou
    Change, Zhi
    Dick, Edward
    Hubbard, Gene
    Cruz, A. Majluf
    Perez, Ce Tene
    Halff, Glenn
    Defronzo, Ralph A.
    Folli, Franco
    DIABETES, 2008, 57 : A476 - A476
  • [26] Enhanced fitness and renal function in Type 2 diabetes
    Nylen, E. S.
    Gandhi, S. M.
    Kheirbek, R.
    Kokkinos, P.
    DIABETIC MEDICINE, 2015, 32 (10) : 1342 - 1345
  • [27] Linking renal and cardiovascular dysfunction in type 2 diabetes
    Jerums, G
    Macisaac, RJ
    Tsalaman-Dris, C
    Panagiotopoulos, S
    Thomas, MC
    Matthews, PG
    Hao, H
    Burrell, LM
    Srivastava, P
    DIABETES, 2005, 54 : A55 - A55
  • [28] Canagliflozin and cardiovascular and renal events in type 2 diabetes
    Guthrie, Robert
    POSTGRADUATE MEDICINE, 2018, 130 (02) : 149 - 153
  • [29] Triglyceride variation and renal function in type 2 diabetes
    Fonseca, R.
    Tavares Bello, C.
    Barreiros, C.
    Moniz, C.
    Limbert, C.
    Duarte, J. Sequeira
    Oliveira, M.
    Azinheira, J.
    Vasconcelos, C.
    DIABETOLOGIA, 2015, 58 : S535 - S535
  • [30] Renal status in elderly patients with type 2 diabetes
    Kazunaga Takamatsu
    Clinical and Experimental Nephrology, 2020, 24 : 53 - 62